The effect of exposing murine splenocytes to UVB light, psoralen plus UVA light, or γ-irradiation on in vitro and in vivo immune responses

被引:12
作者
Fast, LD
机构
[1] Rhode Isl Hosp, Div Hematol Oncol, Dept Med, Providence, RI 02903 USA
[2] Brown Univ, Providence, RI 02912 USA
关键词
D O I
10.1046/j.1537-2995.2003.00380.x
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
BACKGROUND: WBCs in blood components are a major factor contributing to immune responses such as GVHD and allommunization that follow transfusion. Irradiation of blood components has been used to regulate the contribution of donor WBCs to these immune responses. A systematic comparison of how the exposure of lymphoid cells to gamma-irradiation, UVB light, or psoralen + UVA light (PUVA) effects immune response was conducted to better define the best type of irradiation to be used in different clinical settings. STUDY DESIGN AND METHODS: Murine spleen cells were irradiated with varying doses and tested for their in vitro ability to be activated, to proliferate in response to mitogen or allogeneic stimulator cells, or to serve as stimulator cells. Irradiated donor cells were also tested for in vivo generation of GVHD, induction of alloantibody production, induction of restricted cytolytic T lymphocytes, and persistence of irradiated cells. RESULTS: In general, increasing amounts of irradiation resulted in increased inhibition of in vitro and in vivo responses, although the doses required for inhibition differed from assay to assay. In contrast, irradiation of donor cells did not always result in inhibition of recipient alloantibody responses but was dependent on the donor-recipient combination that was studied. CONCLUSION: Control of the in vivo outcomes of transfusing allogeneic cells is regulated by the type and dose of irradiation used and by the genotype of the donor and/or recipient.
引用
收藏
页码:576 / 583
页数:8
相关论文
共 45 条
[1]
ANDERSON KC, 1997, GRAFT VS HOST DIS, P587
[2]
Haematopoietic cell transplantation as immunotherapy [J].
Appelbaum, FR .
NATURE, 2001, 411 (6835) :385-389
[3]
Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation [J].
Barr, ML ;
Baker, CJ ;
Schenkel, FA ;
McLaughlin, SN ;
Stouch, BC ;
Starnes, VA ;
Rose, EA .
CLINICAL TRANSPLANTATION, 2000, 14 (02) :162-166
[4]
Photopheresis for the prevention of rejection in cardiac transplantation [J].
Barr, ML ;
Meiser, BM ;
Eisen, HJ ;
Roberts, RF ;
Livi, U ;
Dall'Amico, R ;
Dorent, R ;
Rogers, JG ;
Radovancevic, B ;
Taylor, DO ;
Jeevanandam, V ;
Marboe, CC ;
Franco, EL ;
Ventura, HO ;
Michler, RE ;
Griffith, BP ;
Boyce, SW ;
Reichart, B ;
Gandjbakhch, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (24) :1744-1751
[5]
Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers [J].
Bittencourt, MD ;
Perruche, S ;
Contassot, E ;
Fresnay, SP ;
Baron, MH ;
Angonin, R ;
Aubin, F ;
Hervé, P ;
Tiberghien, P ;
Saas, P .
BLOOD, 2001, 98 (01) :224-230
[6]
CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells [J].
Blazar, BR ;
Lindberg, FP ;
Ingulli, E ;
Panoskaltsis-Mortari, A ;
Oldenborg, PA ;
Iizuka, K ;
Yokoyama, WM ;
Taylor, PA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (04) :541-549
[7]
Integrin-associated protein (CD47) and its ligands [J].
Brown, EJ ;
Frazier, WA .
TRENDS IN CELL BIOLOGY, 2001, 11 (03) :130-135
[8]
Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment [J].
Brown, S ;
Heinisch, I ;
Ross, E ;
Shaw, K ;
Buckley, CD ;
Savill, J .
NATURE, 2002, 418 (6894) :200-203
[9]
Leukocyte reduction of blood components: Public policy and new technology [J].
Dzik, S ;
Aubuchon, J ;
Jeffries, L ;
Kleinman, S ;
Manno, C ;
Murphy, MF ;
Popovsky, MA ;
Sayers, M ;
Silberstein, LE ;
Slichter, SJ ;
Vamvakas, EC .
TRANSFUSION MEDICINE REVIEWS, 2000, 14 (01) :34-52
[10]
Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences [J].
Fadok, VA ;
Bratton, DL ;
Henson, PM .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (07) :957-962